PETS (PetMed Express) Risk Assessment


PETS PetMed Express Inc PETS
56 GF Score
Price $1.95
GF Value $2.87
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is PetMed Express Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of PetMed Express is: High Risk: Sensitive to economic or industry trends.

PetMed Express  (NAS:PETS) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

PetMed Express Risk Assessment Related Terms

PETS vs SHFH, BHIC, SCNX: Risk Assessment Comparison

For the Pharmaceutical Retailers subindustry, PetMed Express's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PetMed Express Risk Assessment vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PetMed Express's Risk Assessment distribution charts can be found below:

* The bar in red indicates where PetMed Express's Risk Assessment falls into.


PETS
56GF Score
PetMed Express Inc PETS
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PetMed Express (PETS) Overvalued in 2026?

Based on GuruFocus' analysis, PetMed Express stock appears to be undervalued. The current stock price of $1.95 is trading 32.1% below its estimated GF Value™ of $2.87. GuruFocus considers PetMed Express to be Possible Value Trap.

Key valuation signals for PETS:

  • Risk Assessment:
  • GF Value™: $2.87 vs. price of $1.95 (32.1% below fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the PETS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PetMed Express Business Description

Other Exchanges PQM:GermanyPQM:Germany
Address 420 South Congress Avenue, Suite 100, Delray Beach, FL, USA, 33445
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
56GF Score

Get the complete analysis for PETS

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.95
Price
$2.87
GF Value